The anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil

This publication has 12 references indexed in Scilit:

• Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy
  Cancer Gene Therapy, 2000
• Evaluation of anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl]guanine (A-5021) in mice
  Antiviral Research, 1999
• THE IMMUNOSUPPRESSIVE AGENT MYCOPHENOLATE MOFETIL MARKEDLY POTENTIATES THE ACTIVITY OF LOBUCAVIR [1R(1??,2??,3??)]-9-[2,3-BIS(HYDROXYMETHYL)-CYCLOBUTYL]GUANINE AGAINST DIFFERENT HERPES VIRUSES1
  Transplantation, 1999
• The Antiherpesvirus Activity of H2G [( R )-9-[4-Hydroxy-2-(Hydroxymethyl)Butyl]Guanine] Is Markedly Enhanced by the Novel Immunosuppressive Agent Mycophenolate Mofetil
  Antimicrobial Agents and Chemotherapy, 1998
• Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir
  Antiviral Research, 1998
• Mode of Action of (1′ S ,2′ R )-9-{[1′,2′-Bis(hydroxymethyl) cycloprop-1′-yl]methyl}guanine (A-5021) against Herpes Simplex Virus Type 1 and Type 2 and Varicella-Zoster Virus
  Antimicrobial Agents and Chemotherapy, 1998
• Antiherpesvirus Activities of (1′ S ,2′ R )-9-{[1′,2′-Bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine (A-5021) in Cell Culture
  Antimicrobial Agents and Chemotherapy, 1998
• Clinical Pharmacokinetics of Mycophenolate Mofetil
  Clinical Pharmacokinetics, 1998
• Mycophenolate Mofetil
  Drugs, 1996
• Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro
  Antimicrobial Agents and Chemotherapy, 1987